These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3813958)

  • 1. Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids.
    Liu JH; Dacus AC
    Arch Ophthalmol; 1987 Feb; 105(2):245-8. PubMed ID: 3813958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure following systemic administration of cannabinoids.
    Green K; Symonds CM; Oliver NW; Elijah RD
    Curr Eye Res; 1982-1983; 2(4):247-53. PubMed ID: 6295702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene.
    Colasanti BK; Powell SR; Craig CR
    Exp Eye Res; 1984 Jan; 38(1):63-71. PubMed ID: 6323206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous vasopressin influences intraocular pressure via the V(1) receptors.
    Gondim EL; Liu JH; Costa VP; Weinreb RN
    Curr Eye Res; 2001 Apr; 22(4):295-303. PubMed ID: 11462169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of central regulation of intraocular pressure using ventriculocisternal perfusion.
    Liu JH; Neufeld AH
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):136-43. PubMed ID: 4038694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in glaucoma: a primary screening procedure.
    Elsohly MA; Harland E; Murphy JC; Wirth P; Waller CW
    J Clin Pharmacol; 1981; 21(S1):472S-478S. PubMed ID: 6271842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
    Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
    Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
    Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
    J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.
    Colasanti BK
    J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    Shook JE; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide.
    Dortch-Carnes J; Russell KR
    Pharmacology; 2006; 77(1):17-24. PubMed ID: 16534251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
    Carney JM; Balster RL; Martin BR; Harris LS
    J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
    Colasanti BK; Craig CR; Allara RD
    Exp Eye Res; 1984 Sep; 39(3):251-9. PubMed ID: 6499952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
    Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
    Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.